US Patent Issued to University of Maryland, College Park on May 13 for "FcRn-targeted mucosal vaccination against influenza infections" (Maryland Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,233, issued on May 13, was assigned to University of Maryland, College Park (College Park, Md.).

"FcRn-targeted mucosal vaccination against influenza infections" was invented by Xiaoping Zhu (Clarksville, Md.), Susan Park-Ochsner (Towson, Md.) and Weizhong Li (College Park, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are peptides comprising a monomeric Fc fragment of an immunoglobulin recognized by a neonatal receptor (FcRn); an influenza HA protein; and a trimerization domain. Disclosed are compositions comprising one or more of the peptides described herein. Disclosed are nucleic acid sequences capable of encoding any one of the p...